8 completed, 1 terminated. 5 Not applicable.
By phase and status
Follow RxSight, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|
Long-Term Clinical Outcomes Of Subjects Enrolled In The RxSight Light Adjustable Lens (LAL) And Light Delivery Device (LDD) New Enrollment Study
Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Aphakia Cataract | | Completed | RxSight, Inc. | 108 | 2025-11-13 | 2026-10-16 |
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
Light Adjustable lens (LAL) and Light Delivery Device (LDD), Control IOL - Aphakia, Cataract | Not applicable | Completed | RxSight, Inc. | 500 | 2021-12-03 | 2025-04-20 |
Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes
Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Aphakia, Cataract | | Completed | RxSight, Inc. | 79 | 2020-05-22 | 2025-02-10 |
A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus
Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Pre-COVID Population, SofPort LI61AO IOL, Tecnis ZCB00 or ZTC150 IOL - Aphakia, Cataract | | Terminated | RxSight, Inc. | 34 | 2019-11-15 | 2025-01-07 |
A Clinical Study to Evaluate The Safety and Effectiveness of Performing 0.50 Diopter Astigmatism Correction on the Commercially Available RxSight Light Adjustable Lens (LAL)
Light Delivery Device (LDD) - Aphakia, Cataract | Not applicable | Completed | RxSight, Inc. | 25 | 2019-07-01 | 2021-06-11 |
Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery
Light Adjustable lens (LAL) and Light Delivery Device (LDD), Control IOL - Aphakia, Cataract | Not applicable | Completed | RxSight, Inc. | 105 | 2018-08-28 | 2021-12-23 |
Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism
RxSight RxLAL - Cataract | Not applicable | Completed | RxSight, Inc. | 55 | 2018-06-19 | 2021-06-09 |
Exploratory Study to Evaluate the Use of the RxSight Light Adjustable Lens (LAL) and the Light Delivery Device (LDD) to Improve Visual Outcomes
Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Aphakia, Cataract | | Completed | RxSight, Inc. | 66 | 2018-06-14 | 2022-05-12 |
Exploratory Study to Evaluate Uncorrected Distance Vision and Quality of Vision After Light Treatments of an Implanted RxSight Light Adjustable Lens (RXLAL) With The Light Delivery Device (LDD) in Subjects With Preoperative Corneal Astigmatism
Light Adjustable lens (LAL) and Light Delivery Device (LDD) - Aphakia, Cataract | Not applicable | Completed | RxSight, Inc. | 21 | 2018-01-26 | 2021-08-06 |
Conditions studied
Cataract (8) · Aphakia (7) · Eye Diseases (1) · Presbyopia (1)
Countries
United States (5) · Mexico (3) · Germany (1) · United Kingdom (1)
Top investigators
Burkhard Dick, MD (1) · Fritz Hengerer, MD (1) · Sathish Srinivasan, MD (1)
Results publications
PMID 41664266, PMID 42302210